Apr 25, 2023 / 06:00PM GMT
Claudia Hui - Bloom Burton & Co. - Moderator
Our second presentation in this room will be ESSA Pharma; presenting will be David Parkinson, President and CEO.
David Parkinson - ESSA Pharma Inc. - President, CEO & Director
Thank you, Claudia, and thank you all for attending. I'm David Parkinson, CEO of ESSA. I'm here with my colleagues. Does it sound strange to you? No stranger than usual?
Okay. I'm David Parkinson. I'm here with Peter Virsik and David Wood, my colleagues, and we're here to tell you about what we're doing at ESSA, which is a unique way to shutting down male hormone or androgen signaling in prostate cancer. We're doing this because we think this is potentially an important next step in the treatment of early prostate cancer, and I'll go through all of that.
We look forward always. ESSA is a company which actually started in Vancouver on the basis of the work of two scientists, a biologist and a chemist, at the University of British Columbia and BCCA. We currently have operations in Vancouver, our financial work, and then
ESSA Pharma Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
Apr 25, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers